Search Results for '
Novartis, MorphoSys Expand Antibody Alliance'
Refine by Dates:
Refine By Content:
All Advanced Degrees Ask The Board Ask The Experts Back Page Bio News & Views Breaking News Business Corner Buyers Guide Companies Cartoons Case Studies Classifieds Collaborations & Alliances Columns Conference Sessions Contracting & Outsourcing CRO News Custom Sourcing News Editorial Executive Perspective Expert's Opinion FDA Watch Features Financial Analysis Financial Reports Getting Results Glossary I Mak India Report Industry Events Industry News Jobs Literature / Brochures Lowe Down Managing Your Careeer News Releases Online Exclusives Outsourcing Survey Packaging & Tracking Pharma Beat Podcasts Posters Preclinical Outsourcing Product Releases Promotions & Movies Provider Survey Salary Survey Services Slideshows Top Companies Report Trials & Filings Videos Webinars White Papers / Tech Papers
Published November 14, 2012
Published December 3, 2007
Novartis and MorphoSys AG have formed a comprehensive, 10-year, $600 million strategic alliance for the discovery and development of biopharmaceuticals. The deal is aimed at establishing a pipeline of innovative drugs, and establishes Novartis as Mor…
Read More »
By Anna Shagako, Clinical Operations Head
By Mr. Deepak Bahri, President
By Bob Muschert, Global Sales & Business Development Director
Published September 16, 2009
Lisa Rojkjaer, M.D. has been appointed vice president and head of clinical development at MorphoSys.
Read More »
Please visit our sister sites: